First Solar, Inc. (FSLR) Q1 2026 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call summary indicates strong financial metrics, optimistic guidance, and strategic expansion plans. The Q&A highlights potential tariff impacts and capacity decisions, but overall, management's responses were positive about future growth and market positioning. The launch of new technology and expansion of domestic capacity are positive catalysts. Although there are some uncertainties, the overall sentiment is positive, suggesting a likely stock price increase in the near term.
Key Financial Performance
Net Sales $1 billion, a record first quarter for the company, grew 24% year-over-year. This growth was driven by a 31% increase in volume, partially offset by lower average sales price reflecting a higher proportion of India deliveries.
Gross Margin 47%, expanded approximately 6 percentage points compared to the first quarter of 2025. The increase was primarily due to a higher volume of modules qualifying for Section 45X tax benefits and significantly lower sales freight costs, including lower detention and demurrage.
Adjusted EBITDA $520 million, above the high end of the first quarter preview range of $400 million to $500 million. Adjusted EBITDA margin was 50%.
Net Income $347 million, up 65% year-over-year with diluted EPS of $3.22.
Operating Expenses $141 million, including R&D of $67 million, up $15 million year-over-year, primarily reflecting perovskite development and ongoing CuRe launch work.
Operating Cash Outflows $215 million, a meaningful decrease from outflow of $608 million in the first quarter of 2025. This reflected normal first quarter working capital dynamics.
Capital Expenditures $119 million, primarily for the South Carolina finishing facility.
Cash Position $2.4 billion of cash, cash equivalents, restricted cash, and marketable securities, with a net cash position of $2 billion, at the high end of the targeted resilient net cash range of approximately $1.5 billion to $2 billion.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
CuRe Technology Launch: CuRe technology has been launched in Perrysburg, with the first Series 6 line ramping as expected. CuRe is expected to deliver up to 8% more lifetime specific energy yield than crystalline silicon Topcon. It is scheduled to be replicated across Series 6 and 7 fleets by the first half of 2028, potentially generating $0.6 billion in additional revenue from technology adjusters.
India Market Expansion: Record sales in India with approximately 1 gigawatt sold domestically at an average selling price of $0.20 per watt. The policy framework in India favors vertically integrated manufacturers like First Solar, supporting both utility-scale and distributed solar applications.
U.S. Market Position: 1.4 gigawatts booked in the U.S. utility-scale market at an average selling price of $0.35 per watt. Domestic production is substantially committed through 2028, with a selective approach to new bookings due to pending trade and policy decisions.
Module Production: Produced 4.3 gigawatts of modules in Q1 2026, with 3 gigawatts from U.S. facilities operating at 96% utilization. South Carolina finishing facility is on track for production start in the second half of 2026.
Cost Efficiencies: Achieved a $22 million reduction in warehouse costs sequentially and reduced sales freight costs to approximately $0.017 per watt, half of last year's costs.
Supply Chain Independence: Strengthened competitive position in the U.S. and India by leveraging domestic manufacturing and independence from Chinese crystalline silicon supply chains.
Intellectual Property Enforcement: U.S. International Trade Commission initiated a Section 337 investigation into intellectual property violations, with an initial determination expected in 11 months.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
International Facility Utilization: Facilities in Malaysia and Vietnam are operating at significantly reduced utilization due to current trade dynamics and lower ASP expectations for internationally produced modules.
Regulatory and Policy Uncertainty: Pending decisions on the 232 polysilicon derivatives tariff and proposed FEOC rulemaking create uncertainty in the U.S. market, impacting booking strategies and pricing clarity.
Intellectual Property Litigation: Ongoing Section 337 investigation with the U.S. International Trade Commission could impact module imports and create legal and operational challenges.
Supply Chain and Trade Dynamics: Dependence on international production facilities and trade remedy enforcement in the U.S. could disrupt supply chains and affect operational efficiency.
Market Pricing Pressure: Lower average selling prices in India and constrained demand for internationally produced modules could impact revenue and profitability.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
CuRe Technology Rollout: CuRe technology is scheduled to be replicated across the Series 6 and 7 fleet through the first half of 2028, potentially generating up to $0.6 billion in additional revenue from technology adjusters, with the majority anticipated in 2027 and 2028.
South Carolina Facility: The South Carolina finishing facility is on track to start production in the second half of 2026, with equipment installation beginning this quarter. This facility is expected to optimize freight, tariff, and domestic content outcomes while benefiting from Section 45X module assembly tax credits.
India Market Guidance: Production in India is largely expected to be sold domestically at near full capacity in a book-and-bill market. Approximately 1 gigawatt was sold in the first quarter at an average selling price of $0.20 per watt.
U.S. Market Guidance: Domestic production is substantially committed through 2028 under existing contracts, providing pricing clarity through this period. Gross bookings in the U.S. during the first quarter were 0.9 gigawatts at an average selling price of $0.34 per watt.
International Fleet Utilization: Demand for Series 6 modules produced in Malaysia and Vietnam remains constrained, leading to reduced production levels.
Full Year 2026 Guidance: The company reaffirmed its full-year 2026 guidance, expecting second-quarter volumes sold between 3.4 and 4 gigawatts and adjusted EBITDA of $400 million to $500 million.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Why are module gross margins expected to remain flat in Q2 despite improvements in freight costs and warehousing?
A:Gross margins are expected to remain flat in Q2 due to lower utilization rates in Malaysia and Vietnam, leading to underutilization charges. Additionally, the assumption on tariffs, including Section 122 tariffs, impacts the gross margin outlook. Incremental volume and potential tariff changes in the second half of the year could improve margins.
Q:What is the average selling price (ASP) trend for U.S. bookings, and what factors are influencing it?
A:The ASP for U.S. bookings was $0.34 in Q1, with recent bookings in March and April implying higher prices at $0.36-$0.37 per watt. Factors influencing ASP include strong strategic partnerships, disciplined market engagement, and customer acquisitions driving incremental volume.
Q:What is the impact of the CuRe product launch on ASP and adders?
A:The CuRe product launch is transitioning pricing to include the technology's full entitlement, reducing the need for adders. Currently, the blended average adder is around $0.015, but future contracts will likely embed energy attributes in the base price, eliminating separate adders.
Q:What is the status of Southeast Asian capacity and its potential future?
A:Southeast Asian capacity is being maintained as an option, with decisions dependent on policy clarity around Section 232 tariffs. Potential outcomes include running at full capacity, adding a finishing line in the U.S., or shutting down capacity. Approximately 1.8-2 gigawatts of capacity is in play, contingent on tariff decisions.
Q:How will Section 232 changes impact aluminum and module imports from Southeast Asia?
A:Aluminum imports will continue to be subject to applicable Section 232 tariffs. Semi-finished products from Southeast Asia will include glass without aluminum frames, which will be imported separately and subject to tariffs.
Q:What is the company's response to India's proposed efficiency requirements for PV modules?
A:The company plans to launch the CuRe product in India in 2024, which will improve efficiency and energy attributes. They are also engaging with Indian authorities to educate them on the value of energy attributes over labeled efficiency.
Q:What is the decision-making process for Southeast Asian offtake agreements?
A:The decision depends on Section 232 tariff outcomes, which will influence pricing and risk allocation. Options include running at full capacity, adding a finishing line in the U.S., or shutting down capacity. A decision is expected in Q2 2023.
Q:What is the framework and timing for the Section 232 decision?
A:The Section 232 decision framework may include a minimum import price or specific tariffs. The decision is expected by the end of Q2 2023, but timing could shift depending on other events.
Q:What are the plans for the perovskite pilot line and its expected performance?
A:A 1-gigawatt perovskite pilot line will be launched in 2027 in Perrysburg, Ohio. The focus will be on validating the durability and performance of perovskite technology in the field. Initial costs will be higher due to the pilot scale.
Q:What is the impact of domestic capacity expansion on pricing and customer value?
A:Domestic capacity expansion, including the South Carolina facility, enhances customer value by increasing domestic content and enabling higher realization of domestic content bonuses for ITC. This creates opportunities for competitive pricing and broader project eligibility.
Q:How is the company balancing India capacity between domestic and U.S. markets?
A:The company is focusing on strong demand in India, which offers high gross margins. Limited volumes may be shipped to the U.S., but decisions depend on the long-term tariff environment after the Section 122 expiration.
Q:What is the composition and future of the South Carolina facility's capacity?
A:The South Carolina facility will handle semi-finished CuRe products from Vietnam and Malaysia. Approximately 3.5 gigawatts of capacity will be used for this purpose, with no involvement of perovskite technology.
Q:What is the company's stance on licensing its TOPCon patent to Tesla?
A:The company is open to licensing its TOPCon patent to Tesla or other parties, provided fair value is paid. They emphasize the importance of protecting their IP while supporting domestic manufacturing.
Q:Review of Unclear Management Responses
A:Management avoided providing a clear answer on the exact timing and framework of the Section 232 decision, as well as the specific cost implications of the perovskite pilot line. Additionally, there was some vagueness around the potential impact of new domestic capacity on pricing negotiations.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
ALMM cell
ALMM implementation
ASP expectation
Commission Section
Conference Investors
CuRe Series
CuRe launch
CuRe testing
FEOC regulation
IP International
India margin
India presence
India technology
Officer Bradley
Officer overview
Perrysburg Series
Reconciliations measure
Relations Today
Section module
Slide position
Slide start
Slide technology
Solar Conference
Solar Investor
States determination
States headwind
Today discussion
Topcon CuRe
accordance afternoon
action call
adjuster Slide
adjuster backlog
energy yield
independence
lifetime energy
manufacturing footprint
month
record
technology manufacturing
utilization
FSLR Transcript
First Solar, Inc. (FSLR) Q1 2026 Earnings Call Transcript
Positive4-30
The earnings call summary indicates strong financial metrics, optimistic guidance, and strategic expansion plans. The Q&A highlights potential tariff impacts and capacity decisions, but overall, management's responses were positive about future growth and market positioning. The launch of new technology and expansion of domestic capacity are positive catalysts. Although there are some uncertainties, the overall sentiment is positive, suggesting a likely stock price increase in the near term.
First Solar, Inc. (FSLR) Q4 2025 Earnings Call Transcript
Unknown2-24
The earnings call summary shows a mix of positive and negative elements. While the company has strong operating income and a robust cash position, there are concerns about reduced revenue guidance, underutilization of facilities, and lack of EPS guidance for 2026. The Q&A reveals management's evasive responses to some questions, particularly around the lack of EPS guidance and the Oxford PV program. These factors, along with strong pricing environment and strategic shifts, suggest a neutral sentiment, with no clear catalyst for significant stock price movement.
First Solar, Inc. (FSLR) Q3 2025 Earnings Call Transcript
Unknown10-30
The earnings call presents a mixed picture: strong module sales and a record backlog are positive, but declining gross margins and the inability to adjust fixed contracts for new tariffs are concerning. The Q&A highlights risks like rebooking challenges and reliance on international facilities. Despite optimistic guidance and confidence in backlog, these concerns balance out the positive aspects, leading to a neutral sentiment.
First Solar, Inc. (FSLR) Q2 2025 Earnings Call Transcript
Positive7-31
The earnings call summary shows strong financial performance with EPS above guidance, increased net sales, and improved gross margins. The Q&A highlights strategic positioning, with management expressing optimism about demand and pricing trends. Although there are some uncertainties, such as tariff impacts and executive order clarifications, the overall sentiment is positive, especially with strong domestic demand and potential price increases. Despite a lack of clear guidance on some aspects, the financial results and strategic developments suggest a likely positive stock price movement.
FSLR Slides
FSLR Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
